Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
CDI recurrence
Description:
CDI recurrence is the return of Clostridioides difficile infection after an earlier episode has been treated or resolved.
Primary topic:
Clostridium difficile and Clostridium perfringens research (96%)
Related topic:
Clostridium difficile and Clostridium perfringens research (96%)
OpenAlex ID:
keywords/cdi-recurrence
Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
2012
·
T. J. Louie
, K. Cannon
, et al.
·
Clinical Infectious Diseases
·
340
PDF
Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
2012
·
Derrick W. Crook
, A. Sarah Walker
, et al.
·
Clinical Infectious Diseases
·
276
PDF
Continuous Proton Pump Inhibitor Therapy and the Associated Risk of RecurrentClostridium difficileInfection
2015
·
Emily G. McDonald
, Jonathon Milligan
, et al.
·
JAMA Internal Medicine
·
247
Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry
2020
·
Colleen R. Kelly
, Eugene F. Yen
, et al.
·
Gastroenterology
·
240
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial
2023
·
Thomas Louie
, Yoav Golan
, et al.
·
JAMA
·
234
PDF
Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract
2016
·
Jenessa A. Winston
, Casey M. Theriot
·
Anaerobe
·
218
Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial
2016
·
Susy S Hota
, Valerie Sales
, et al.
·
Clinical Infectious Diseases
·
206
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection
2011
·
K. W. Garey
, S. S. Ghantoji
, et al.
·
Journal of Antimicrobial Chemotherapy
·
187
Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis
2012
·
R. Postigo
, J. H. Kim
·
Infection
·
124
A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO)
2017
·
Anna K Barker
, Megan Duster
, et al.
·
Journal of Antimicrobial Chemotherapy
·
114
Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience
2015
·
Olga C. Aroniadis
, Lawrence J. Brandt
, et al.
·
Journal of Clinical Gastroenterology
·
109
Intravenous Immunoglobulin for the Treatment of Clostridium difficile Infection: A Review
2010
·
Marwan S. Abougergi
, John H. Kwon
·
Digestive Diseases and Sciences
·
104
Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids
2020
·
Jenessa A. Winston
, Alissa J. Rivera
, et al.
·
Infection and Immunity
·
102
PDF
Clostridium difficile Infection: An Epidemiology Update
2020
·
Ana C. De Roo
, Scott E. Regenbogen
·
Clinics in Colon and Rectal Surgery
·
93
Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection
2014
·
D. Nathwani
, O. A. Cornely
, et al.
·
Journal of Antimicrobial Chemotherapy
·
92
PDF
A clinical and epidemiological review of non-toxigenic Clostridium difficile
2013
·
Mukil Natarajan
, Seth T. Walk
, et al.
·
Anaerobe
·
88
Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance
2013
·
Kathleen Mullane
·
Therapeutic Advances in Chronic Disease
·
76
Amixicile, a Novel Inhibitor of Pyruvate:Ferredoxin Oxidoreductase, Shows Efficacy against Clostridium difficile in a Mouse Infection Model
2012
·
Cirle A. Warren
, Edward van Opstal
, et al.
·
Antimicrobial Agents and Chemotherapy
·
72
Poor Functional Status as a Risk Factor for Severe Clostridium difficile Infection in Hospitalized Older Adults
2013
·
Krishna Rao
, Dejan Micic
, et al.
·
Journal of the American Geriatrics Society
·
71
Treatment ofClostridioides (Clostridium) difficileinfection
2019
·
Oksi Jarmo
, Anttila Veli-Jukka
, et al.
·
Annals of Medicine
·
70
PDF
Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates
2019
·
Alice Y Guh
, Kelly M Hatfield
, et al.
·
Clinical Infectious Diseases
·
62
PDF
Broad Coverage of Genetically Diverse Strains of Clostridium difficile by Actoxumab and Bezlotoxumab Predicted by In Vitro Neutralization and Epitope Modeling
2014
·
Lorraine D. Hernandez
, Fred Racine
, et al.
·
Antimicrobial Agents and Chemotherapy
·
61
Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection
2015
·
Marco Falcone
, Alessandro Russo
, et al.
·
Antimicrobial Agents and Chemotherapy
·
59
Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin
2018
·
Cheleste M. Thorpe
, Anne V. Kane
, et al.
·
PLoS ONE
·
58
PDF
Burden of Clostridium difficile Infection in Long-Term Care Facilities in Monroe County, New York
2012
·
Deepa Pawar
, Rebecca Tsay
, et al.
·
Infection Control and Hospital Epidemiology
·
57
Show more works
View as search
Works count:
406
Citation count:
6,062
Year
Topic
Type